Lipe & Dalton
TMO icon

Lipe & Dalton’s Thermo Fisher Scientific TMO Stock Holding History

Lipe & Dalton’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.76M Hold
8,533
– – 2.66% 8
2026
Q2 		$4.28M Sell
8,533
-207
-2% -$99.4K 1.99% 18
2026
Q1 		$4.3M Sell
8,740
-360
-4% -$195K 2.25% 12
2025
Q4 		$5.27M Sell
9,100
-154
-2% -$87.1K 2.6% 10
2025
Q3 		$4.49M Sell
9,254
-150
-2% -$69.8K 2.22% 12
2025
Q2 		$3.81M Buy
+9,404
New +$3.93M 2.06% 16

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Lipe & Dalton's TMO Position: Q3 2026 in Review

Lipe & Dalton held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 8,533 shares worth $5.76M. The position accounts for 2.66% of the portfolio, ranked #8.

Lipe & Dalton first reported a position in TMO in Q2 2025 and has held it in 6 quarters since. 1,246 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Lipe & Dalton held 8,533 shares of Thermo Fisher Scientific worth $5.76M as of Q3 2026.
  • Lipe & Dalton left its Thermo Fisher Scientific share count unchanged in Q3 2026.
  • Thermo Fisher Scientific made up 2.66% of Lipe & Dalton's portfolio in Q3 2026, its #8 holding.
  • Lipe & Dalton first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 6 quarters since.
  • 1,246 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Lipe & Dalton's 13F filing for Q3 2026, filed 15 Oct 2026.